you are here: HomeNewsBusiness

Coronavirus pandemic | Mahindra CIE temporarily suspends production activities

The operations at Karnataka plants shall be suspended from March 25, 2020 till March 31, 2020. However, the same is subject to review of rapidly changing circumstances, Mahindra CIE Automotive added.

March 24, 2020 / 01:08 PM IST
auto parts

auto parts

  • bselive
  • nselive
Todays L/H

Auto component firm Mahindra CIE Automotive has suspended production activities in all plants across the country, except in Karnataka, due to the coronavirus pandemic.

The company and its subsidiaries, including Aurangabad Electricals Ltd, have suspended operations at all the manufacturing units in India, except in Karnataka, from March 23 till the government restrictions are removed, Mahindra CIE Automotive said in a regulatory filing.

The operations at Karnataka plants shall be suspended from March 25, 2020 till March 31, 2020. However, the same is subject to review of rapidly changing circumstances, it added.

The company's subsidiary in Italy, Metallcastello SpA, has also suspended its operation from March 23, Mahindra CIE Automotive said.

The closure is expected till April 6, 2020, it added.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

"In Germany, due to the reduction of the demand due to the coronavirus outbreak, our subsidiary Schoneweiss & Co GmbH will be also closed for next two weeks," it said.

The other two German subsidiaries, Gesenkschmiede Schneider GmbH and Falkenroth Umformtechnik GmbH will continue its operation, but at a reduced output, during this period, it noted.

Besides, the company's Spain-based subsidiaries will stop operations for next two weeks to adapt output to the new demand, it added.
first published: Mar 24, 2020 01:00 pm

stay updated

Get Daily News on your Browser